CIK 0001745999 · Large accelerated filer
Beam Therapeutics Inc.
Sign in to watch- Ticker
- BEAM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857-327-8775
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Former names
- Beam Therapeutics Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,193,310
- in 2 filings, $1.2M under 10b5-1 plans
Net −$1,193,310. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-29 | Evans John M. CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,337 | 230,804 | ||
| 2026-06-26 | FMR LLC 10% owner | Sale | −251,488 | $35.26 | $8.9M | 854,583 |
| 2026-06-25 | FMR LLC 10% owner | Sale | −33,372 | $35.12 | $1.2M | 1,106,071 |
| 2026-06-17 | Ciaramella Giuseppe President | Option exercise | +6,505 | $0.67 | $4K | 224,911 |
| 2026-06-17 | Ciaramella Giuseppe President | Option exercise | +29,000 | $1.03 | $30K | 253,911 |
| 2026-06-17 | Ciaramella Giuseppe President | Option exercise · Stock Option (Right to Buy) | −6,505 | 0 | ||
| 2026-06-17 | Ciaramella Giuseppe President | Option exercise · Stock Option (Right to Buy) | −29,000 | 56,946 | ||
| 2026-06-03 | Fishman Mark Director | Grant or award · Stock Option (Right to Buy) | +19,676 | 19,676 | ||
| 2026-06-03 | Guindo Chirfi Director | Grant or award · Stock Option (Right to Buy) | +19,676 | 19,676 | ||
| 2026-06-03 | Shaw Christi Director | Grant or award · Stock Option (Right to Buy) | +19,676 | 19,676 | ||
| 2026-06-03 | Walsh Kathleen E Director | Grant or award · Stock Option (Right to Buy) | +19,676 | 19,676 | ||
| 2026-06-03 | MARAGANORE JOHN Director | Grant or award · Stock Option (Right to Buy) | +19,676 | 19,676 | ||
| 2026-06-03 | COOPER GRAHAM K Director | Grant or award · Stock Option (Right to Buy) | +19,676 | 19,676 | ||
| 2026-04-01 | Evans John M. CEO | Sale 10b5-1 | −30,078 | $24.58 | $739K | 1,047,205 |
| 2026-04-01 | Simon Amy Chief Medical Officer | Sale 10b5-1 | −6,700 | $24.58 | $165K | 102,735 |
| 2026-04-01 | Cavanagh Bethany J SVP, Finance and Treasurer | Sale 10b5-1 | −3,242 | $24.58 | $80K | 51,171 |
| 2026-04-01 | Bellon Christine Chief Legal Officer | Sale 10b5-1 | −5,956 | $24.58 | $146K | 109,711 |
| 2026-04-01 | Ciaramella Giuseppe President | Sale 10b5-1 | −11,810 | $24.58 | $290K | 218,406 |
| 2026-03-31 | Bellon Christine Chief Legal Officer | Grant or award | +20,000 | 115,667 | ||
| 2026-03-31 | Cavanagh Bethany J SVP, Finance and Treasurer | Grant or award | +20,000 | 54,813 |
Page 2 of 32 · 630 trades